Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ackermann

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Kidney International Reports|April 14, 2025
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal CrisisAïcha Kante, Paul Legendre, Bérangère S Joly, et al.
Rheumatology (Oxford, England)|September 5, 2022
Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognosesPaul Breillat, Kuberaka Mariampillai, Paul Legendre, et al.
Journal of the American Academy of Dermatology|February 10, 2019
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosisNoémie Abisror, Arsène Mekinian, Agnès Dechartres, et al.
JAMA Dermatology|December 8, 2022
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 PatientsAnastasia Dupré, Nathalie Morel, Cécile Yelnik, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
Rheumatology (Oxford, England)|September 9, 2020
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)Julie Chezel, Nathalie Costedoat-Chalumeau, Cedric Laouénan, et al.
Journal of Proteome Research|October 1, 2024
Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19Jean-Marie Michot, Vito Dozio, Julien Rohmer, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
Annals of Internal Medicine|July 28, 2025
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled TrialBenjamin Terrier, Grégory Pugnet, Claire de Moreuil, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Kidney International Reports|April 14, 2025
Pilot Study of Diagnostic Performances of Vascular Biomarkers Soluble fms-Like Tyrosine Kinase and Placental Growth Factor in Scleroderma Renal CrisisAïcha Kante, Paul Legendre, Bérangère S Joly, et al.
Rheumatology (Oxford, England)|September 5, 2022
Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognosesPaul Breillat, Kuberaka Mariampillai, Paul Legendre, et al.
Journal of the American Academy of Dermatology|February 10, 2019
Abnormal T-cell phenotype in episodic angioedema with hypereosinophilia (Gleich syndrome): Frequency, clinical implication, and prognosisNoémie Abisror, Arsène Mekinian, Agnès Dechartres, et al.
JAMA Dermatology|December 8, 2022
Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 PatientsAnastasia Dupré, Nathalie Morel, Cécile Yelnik, et al.
Medicine|August 29, 2013
The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 CasesFanny Legrand, Aline Renneville, Elizabeth MacIntyre, et al.
Rheumatology (Oxford, England)|September 9, 2020
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study)Julie Chezel, Nathalie Costedoat-Chalumeau, Cedric Laouénan, et al.
Journal of Proteome Research|October 1, 2024
Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19Jean-Marie Michot, Vito Dozio, Julien Rohmer, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
Annals of Internal Medicine|July 28, 2025
Rituximab Versus Conventional Therapy for Remission Induction in Eosinophilic Granulomatosis With Polyangiitis : A Randomized Controlled TrialBenjamin Terrier, Grégory Pugnet, Claire de Moreuil, et al.
Clinical and Experimental Rheumatology|May 17, 2022
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control studyMarie Péan de Ponfilly-Sotier, Vincent Jachiet, Ygal Benhamou, et al.
Pageof 3